The incidence, natural history, biology, and treatment of transformed lymphomas
about
Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacyOral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial.Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regionsBCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphomaTreatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach.Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantationHigh-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era.High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study.Enzastaurin hydrochloride for lymphoma: reassessing the results of clinical trials in light of recent advances in the biology of B-cell malignancies.Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment.Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database.
P2860
Q30659342-A8DD7431-1E3F-4CA9-8DBE-6BDCBCF64CA7Q33406742-98A00061-7623-4E5C-AD62-420AE405383EQ34476318-A36CCD02-D409-49F2-AB15-B0CE22C677AEQ35004965-30A49C49-EA78-490F-89B1-B3FA2AF02351Q35166811-E611A7CE-D4CE-4AB4-AEC3-8CF041975C98Q36837765-19269557-CF74-4F8D-803D-BCB0F659B189Q36842993-227A46B4-A06A-4A9C-ADB1-53FF29F3CD53Q37829460-6F030C1F-842E-4F2D-831D-F6221F15FAC8Q37884624-98B70F0D-8C6B-4154-AB45-8BFD4C638521Q38398064-49E2BFAC-6AE2-45AC-A86A-861378B8D694Q39335736-B27A88BD-6DE1-4C51-822E-DD514461D414
P2860
The incidence, natural history, biology, and treatment of transformed lymphomas
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The incidence, natural history, biology, and treatment of transformed lymphomas
@ast
The incidence, natural history, biology, and treatment of transformed lymphomas
@en
The incidence, natural history, biology, and treatment of transformed lymphomas
@en-gb
The incidence, natural history, biology, and treatment of transformed lymphomas
@nl
type
label
The incidence, natural history, biology, and treatment of transformed lymphomas
@ast
The incidence, natural history, biology, and treatment of transformed lymphomas
@en
The incidence, natural history, biology, and treatment of transformed lymphomas
@en-gb
The incidence, natural history, biology, and treatment of transformed lymphomas
@nl
prefLabel
The incidence, natural history, biology, and treatment of transformed lymphomas
@ast
The incidence, natural history, biology, and treatment of transformed lymphomas
@en
The incidence, natural history, biology, and treatment of transformed lymphomas
@en-gb
The incidence, natural history, biology, and treatment of transformed lymphomas
@nl
P1476
The incidence, natural history, biology, and treatment of transformed lymphomas
@en
P2093
S. H. Bernstein
W. R. Burack
P304
P356
10.1182/ASHEDUCATION-2009.1.532
P407
P577
2009-01-01T00:00:00Z